Last updated: 21 August 2024 at 4:03pm EST

Karen Zaderej Net Worth




The estimated Net Worth of Karen L. Zaderej is at least $3.64 Million dollars as of 19 August 2024. Ms. Zaderej owns over 12,500 units of Axogen stock worth over $219,120 and over the last 13 years she sold AXGN stock worth over $2,416,191. In addition, she makes $999,963 as Chairman of the Board, President, and Chief Executive Officer at Axogen.

Ms. Zaderej AXGN stock SEC Form 4 insiders trading

Karen has made over 36 trades of the Axogen stock since 2011, according to the Form 4 filled with the SEC. Most recently she bought 12,500 units of AXGN stock worth $99,750 on 19 August 2024.

The largest trade she's ever made was exercising 175,000 units of Axogen stock on 2 August 2018 worth over $479,500. On average, Karen trades about 18,722 units every 70 days since 2011. As of 19 August 2024 she still owns at least 16,500 units of Axogen stock.

You can see the complete history of Ms. Zaderej stock trades at the bottom of the page.





Karen Zaderej biography

Karen L. Zaderej serves as Chairman of the Board, President, Chief Executive Officer of the Company. She has served as Axogen’s President, Chief Executive Officer, a member of our board of directors (the “Board of Directors”) since September 2011 and became the Chairman of our Board of Directors in May 2018. She has served as the Chief Executive Officer of Axogen, and a member of Axogen’s board of directors since May 2010. Ms. Zaderej joined Axogen in May 2006 and served as Vice President of Marketing and Sales from May 2006 to October 2007 and as Chief Operating Officer from October 2007 to May 2010. From October 2004 to May 2006, Ms. Zaderej worked for Zaderej Medical Consulting, a consulting firm she founded, which assisted medical device companies in building and executing successful commercialization plans. From 1987 to 2004, Ms. Zaderej worked at Ethicon, Inc., a Johnson & Johnson company, where she held senior positions in marketing, business development, and research & development, as well as ran a manufacturing business. Ms. Zaderej is a Director of Viveve Medical, Inc., a public women's intimate health company. Ms. Zaderej has a MBA from the Kellogg Graduate School of Business and a BS in Chemical Engineering from Purdue University.

What is the salary of Karen Zaderej?

As the Chairman of the Board, President, and Chief Executive Officer of Axogen, the total compensation of Karen Zaderej at Axogen is $999,963. There are 1 executives at Axogen getting paid more, with Eric Sandberg having the highest compensation of $1,113,440.



How old is Karen Zaderej?

Karen Zaderej is 58, she's been the Chairman of the Board, President, and Chief Executive Officer of Axogen since 2018. There are 7 older and 7 younger executives at Axogen. The oldest executive at Axogen Inc. is Guido Neels, 71, who is the Independent Director.

What's Karen Zaderej's mailing address?

Karen's mailing address filed with the SEC is C/O EYEPOINT PHARMACEUTICALS, INC., 480 PLEASANT STREET, WATERTOWN, MA, 02472.

Insiders trading at Axogen

Over the last 13 years, insiders at Axogen have traded over $73,805,978 worth of Axogen stock and bought 504,297 units worth $3,119,117 . The most active insiders traders include James E Deerfield Mgmt L.P...., Guido J Neels, and Karen L. Zaderej. On average, Axogen executives and independent directors trade stock every 21 days with the average trade being worth of $455,132. The most recent stock trade was executed by John Johnson on 1 September 2024, trading 11,904 units of AXGN stock currently worth $158,085.



What does Axogen do?

it's time to rethink nerve repair! axogen (nasdaq: axgn) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. people suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. damage may cause loss of function and feeling. axogen is bringing the science of nerve repair to life with its avance® nerve graft which axogen believes is the first and only commercially available allograft for bridging nerve discontinuities, axoguard® nerve connector, a coaptation aid allowing for close approximation of severed nerves, and axoguard® nerve protector that protects nerves during the healing process.



What does Axogen's logo look like?

Axogen Inc. logo

Complete history of Ms. Zaderej stock trades at Axogen, Viveve Medical Inc, and EyePoint Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
19 Aug 2024 Karen L. Zaderej
Buy 12,500 $7.98 $99,750
19 Aug 2024
16,500
11 Jul 2024 Karen L. Zaderej
Option 2,000 $9.91 $19,820
11 Jul 2024
4,000
11 Jul 2023 Karen L. Zaderej
Option 2,000 $9.20 $18,400
11 Jul 2023
2,000
16 Mar 2024 Karen L. Zaderej
CEO
Option 110,322 $7.68 $847,273
16 Mar 2024
1,146,954
16 Mar 2023 Karen L. Zaderej
CEO
Option 37,975 $8.27 $314,053
16 Mar 2023
1,050,670
27 Dec 2022 Karen L. Zaderej
CEO
Option 4,400 $9.44 $41,536
27 Dec 2022
1,012,695
15 Dec 2022 Karen L. Zaderej
CEO
Option 26,746 $5.09 $136,137
15 Dec 2022
1,008,295
16 Mar 2022 Karen L. Zaderej
CEO
Option 25,950 $8.20 $212,790
16 Mar 2022
966,333
27 Dec 2021 Karen L. Zaderej
CEO
Option 4,400 $9.74 $42,856
27 Dec 2021
927,429
20 Dec 2021 Karen L. Zaderej
CEO
Option 3,125 $9.24 $28,875
20 Dec 2021
924,272
24 Nov 2021 Karen L. Zaderej
CEO
Option 52,375 $8.95 $468,756
24 Nov 2021
921,147
12 Aug 2021 Karen L. Zaderej
CEO
Option 54,754 $3.88 $212,446
12 Aug 2021
868,772
6 Aug 2021 Karen L. Zaderej
CEO
Option 75,000 $5.09 $381,750
6 Aug 2021
855,018
16 Apr 2021 Karen L. Zaderej
CEO
Option 100,000 $5.09 $509,000
16 Apr 2021
765,912
25 Mar 2021 Karen L. Zaderej
CEO
Option 34,500 $3.67 $126,615
25 Mar 2021
665,912
8 Jan 2021 Karen L. Zaderej
CEO
Sale 65,000 $20.00 $1,300,000
8 Jan 2021
609,099
27 Dec 2020 Karen L. Zaderej
CEO
Sale 3,500 $17.81 $62,335
27 Dec 2020
674,099
23 Dec 2020 Karen L. Zaderej
CEO
Option 19,375 $4.81 $93,194
23 Dec 2020
666,094
18 Dec 2020 Karen L. Zaderej
CEO
Sale 1,275 $16.42 $20,936
18 Dec 2020
646,719
9 Nov 2020 Karen L. Zaderej
CEO
Sale 14,000 $14.53 $203,420
9 Nov 2020
644,869
16 Apr 2020 Karen L. Zaderej
CEO
Option 11,625 $4.81 $55,916
16 Apr 2020
658,869
9 Aug 2019 Karen L. Zaderej
CEO
Buy 75,000 $13.50 $1,012,500
9 Aug 2019
593,280
29 May 2019 Karen L. Zaderej
CEO
Option 18,056 $0.27 $4,875
29 May 2019
510,280
19 Dec 2018 Karen L. Zaderej
CEO
Option 30,000 $2.74 $82,200
19 Dec 2018
476,209
19 Nov 2018 Karen L. Zaderej
CEO
Option 70,000 $2.74 $191,800
19 Nov 2018
452,970
13 Nov 2018 Karen L. Zaderej
CEO
Sale 25,000 $33.18 $829,500
13 Nov 2018
382,970
2 Aug 2018 Karen L. Zaderej
CEO
Option 175,000 $2.74 $479,500
2 Aug 2018
418,030
7 Oct 2016 Karen L. Zaderej
CEO
Buy 10,000 $7.50 $75,000
7 Oct 2016
242,147
27 May 2015 Karen L. Zaderej
CEO
Buy 3,325 $3.16 $10,507
27 May 2015
232,147
3 Jun 2014 Karen L. Zaderej
CEO
Buy 5,000 $2.43 $12,150
3 Jun 2014
334,056
12 May 2014 Karen L. Zaderej
CEO
Buy 5,000 $2.70 $13,500
12 May 2014
329,056
13 Mar 2014 Karen L. Zaderej
CEO
Option 72,348 $0.27 $19,534
13 Mar 2014
209,222
14 Aug 2013 Karen L. Zaderej
CEO
Buy 8,334 $3.00 $25,002
14 Aug 2013
129,124
10 Dec 2012 Karen L. Zaderej
CEO
Buy 900 $2.50 $2,250
10 Dec 2012
120,790
20 Nov 2012 Karen L. Zaderej
CEO
Buy 100 $2.69 $269
20 Nov 2012
119,890
19 Dec 2011 Karen L. Zaderej
CEO
Option 76,741 $0.27 $20,720
19 Dec 2011
119,790


Axogen executives and stock owners

Axogen executives and other stock owners filed with the SEC include: